{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T19:26:27Z","timestamp":1793906787660,"version":"4.8.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":121,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pharmthera.2025.108875","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:07:59Z","timestamp":1746558479000},"page":"108875","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Management of drug-resistant hypertension as a heterogeneous disorder"],"prefix":"10.1016","volume":"271","author":[{"given":"Reza","family":"Tabrizchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2025.108875_bb0005","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/HJH.0b013e328351d08a","article-title":"Resistant hypertension and obstructive sleep apnea in the setting of kidney disease","volume":"30","author":"Abdel-Kader","year":"2012","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0010","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ckj\/sfac234","article-title":"A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease","volume":"16","author":"Agarwal","year":"2022","journal-title":"Clinical Kidney Journal"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/HJH.0000000000003330","article-title":"Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes","volume":"41","author":"Agarwal","year":"2023","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0020","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1111\/bcp.13706","article-title":"Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence","volume":"84","author":"Avataneo","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0025","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1161\/HYPERTENSIONAHA.110.156976","article-title":"Divergent results using clinic and ambulatory blood pressure: Report of a darusentan-resistant hypertension trial","volume":"56","author":"Bakris","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0030","article-title":"Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: A cross-sectional cohort study in secondary care","volume":"7","author":"de Beus","year":"2017","journal-title":"British Medical Journal Open"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0035","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/HYPERTENSIONAHA.122.20503","article-title":"Effects of renal denervation on sympathetic nerve traffic and correlates in drug-resistant and uncontrolled hypertension: A systematic review and meta-analysis","volume":"80","author":"Biffi","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0045","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","article-title":"Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: Results from the double-blind, randomized, placebo-controlled rheos pivotal trial","volume":"58","author":"Bisognano","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0541","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1524-6175.2007.07244.x","article-title":"Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study","volume":"9","author":"Black","year":"2007","journal-title":"Journal Clinical Hypertension (Greenwich)"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0050","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/CIRCULATIONAHA.121.055329","article-title":"Effects of lifestyle modification on patients with resistant hypertension: Results of the TRIUMPH randomized clinical trial","volume":"144","author":"Blumenthal","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/HCR.0000000000000801","article-title":"Effects of lifestyle modification on psychosocial function in patients with resistant hypertension: Secondary outcomes from the Triumph randomized clinical trial","volume":"44","author":"Blumenthal","year":"2024","journal-title":"Journal of Cardiopulmonary Rehabilitation and Prevention"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0060","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/HJH.0b013e3283551e98","article-title":"Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: A prospective, randomized, open blinded endpoint study","volume":"30","author":"Bobrie","year":"2012","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0065","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s11606-008-0547-7","article-title":"Racial differences in blood pressure control: Potential explanatory factors","volume":"23","author":"Bosworth","year":"2008","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0070","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.jacc.2013.10.067","article-title":"Therapeutic drug monitoring facilitates blood pressure control in resistant hypertension","volume":"63","author":"Brinker","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0075","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1097\/HJH.0000000000002184","article-title":"Clinical characteristics, antihypertensive medication use and blood pressure control among patients with treatment-resistant hypertension: The survey of patients with treatment resistant hypertension study","volume":"37","author":"Carcel","year":"2019","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0080","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1748-1716.1958.tb01615.x","article-title":"Cardiovascular effects of direct stimulation of the carotid sinus nerve in man","volume":"44","author":"Carlsten","year":"1958","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/hr.2010.183","article-title":"Difficult-to-control arterial hypertension or uncooperative patients? The assessment of serum antihypertensive drug levels to differentiate non-responsiveness from non-adherence to recommended therapy","volume":"34","author":"Ceral","year":"2011","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0090","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2147\/VHRM.S383007","article-title":"Effect of sequential nephron blockade versus dual renin-angiotensin system blockade plus bisoprolol in the treatment of resistant hypertension, a randomized controlled trial (resistant hypertension on treatment - ResHypOT)","volume":"18","author":"Cestario","year":"2022","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0095","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0100","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/eurheartj\/eht295","article-title":"Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences","volume":"34","author":"Chowdhury","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1152\/physrev.1992.72.1.231","article-title":"Long-term control of arterial blood pressure","volume":"72","author":"Cowley","year":"1992","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1253\/circj.CJ-16-0870","article-title":"Neurohumoral and endothelial responses to heated water-based exercise in resistant hypertensive patients","volume":"81","author":"Cruz","year":"2017","journal-title":"Circulation Journal"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0545","article-title":"Economic impact of medication non-adherence by disease groups: a systematic review","volume":"8","author":"Cutler","year":"2018","journal-title":"British Medical Journal Open"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0115","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ajh\/hpv031","article-title":"The effects of aldosterone antagonists in patients with resistant hypertension: A meta-analysis of randomized and nonrandomized studies","volume":"28","author":"Dahal","year":"2015","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0120","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jacc.2012.12.061","article-title":"Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients","volume":"61","author":"De Nicola","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0125","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1161\/HYPERTENSIONAHA.119.13009","article-title":"Sympathetic nerve traffic and arterial baroreflex function in apparent drug-resistant hypertension","volume":"74","author":"Dell\u2019Oro","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0130","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/01.HYP.0000113047.47711.fa","article-title":"The sympathetic nervous system and hypertension: Recent developments","volume":"43","author":"DiBona","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/01.hjh.0000199800.72563.26","article-title":"Lifestyle interventions to reduce raised blood pressure: A systematic review of randomized controlled trials","volume":"24","author":"Dickinson","year":"2006","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/HYPERTENSIONAHA.112.197780","article-title":"Aerobic exercise reduces blood pressure in resistant hypertension","volume":"60","author":"Dimeo","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0145","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/MLR.0b013e3181d567bd","article-title":"Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs","volume":"48","author":"Dragomir","year":"2010","journal-title":"Medical Care"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.115.05449","article-title":"Refractory hypertension: Evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure","volume":"66","author":"Dudenbostel","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0155","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1097\/00004872-200411000-00026","article-title":"Low-renin status in therapy-resistant hypertension: A clue to efficient treatment","volume":"22","author":"Eide","year":"2004","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0160","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/HJR.0b013e3280128bbb","article-title":"Effect of exercise on blood pressure control in hypertensive patients","volume":"14","author":"Fagard","year":"2007","journal-title":"European Journal of Cardiovascular Prevention and Rehabilitation"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0165","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jacc.2016.11.034","article-title":"Improving medication adherence in cardiometabolic disease: Practical and regulatory implications","volume":"69","author":"Ferdinand","year":"2017","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0170","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","article-title":"Primary medication non-adherence: Analysis of 195,930 electronic prescriptions","volume":"25","author":"Fischer","year":"2010","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.20452\/pamw.2648","article-title":"Assessment of adherence to treatment in patients with resistant hypertension using toxicological serum analysis. A subgroup evaluation of the RESIST-POL study","volume":"125","author":"Florczak","year":"2015","journal-title":"Polish Archives of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0180","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1002\/ehf2.12832","article-title":"Sequential nephron blockade with combined diuretics improves diastolic function in patients with resistant hypertension","volume":"7","author":"Fouassier","year":"2020","journal-title":"ESC Heart Failure"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10286-017-0417-7","article-title":"Baroreflex gain and vasomotor sympathetic modulation in resistant hypertension","volume":"27","author":"Freitas","year":"2017","journal-title":"Clinical Autonomic Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0190","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/ajh.2010.154","article-title":"Sympathetic neural activity in hypertension and related diseases","volume":"23","author":"Grassi","year":"2010","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/MBP.0000000000000000","article-title":"Effects of short-term heated water-based exercise training on systemic blood pressure in patients with resistant hypertension: A pilot study","volume":"18","author":"Guimar\u00e3es","year":"2013","journal-title":"Blood Pressure Monitoring"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijcard.2014.01.100","article-title":"Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: A randomized controlled trial (HEx trial)","volume":"172","author":"Guimaraes","year":"2014","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0205","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","article-title":"Risk factors for nonadherence to antihypertensive treatment","volume":"69","author":"Gupta","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0210","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1097\/HJH.0000000000000586","article-title":"Acute on\/off effects and chronic blood pressure reduction after long-term baroreflex activation therapy in resistant hypertension","volume":"33","author":"Halbach","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0215","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.3399\/bjgp19X705077","article-title":"Measuring adherence to therapy in apparent treatment-resistant hypertension: A feasibility study in Irish primary care","volume":"69","author":"Hayes","year":"2019","journal-title":"British Journal of General Practice"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0220","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.115.06486","article-title":"Acute response to unilateral unipolar electrical carotid sinus stimulation in patients with resistant arterial hypertension","volume":"67","author":"Heusser","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0225","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.119.13925","article-title":"Efficacy of electrical baroreflex activation is independent of peripheral chemoreceptor modulation","volume":"75","author":"Heusser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0230","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/j.1532-5415.2012.04037.x","article-title":"Ethnic disparities in adherence to antihypertensive medications of medicare part D beneficiaries","volume":"60","author":"Holmes","year":"2012","journal-title":"Journal of the American Geriatric Society"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: Results from the Barostim neo trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jash.2012.02.004","article-title":"Disparities in adherence to and persistence with antihypertensive regimens: An exploratory analysis from a community-based provider network","volume":"6","author":"Ishisaka","year":"2012","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0245","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jch.13597","article-title":"Maintenance of long-term blood pressure control and vascular health by low-dose amiloride-based therapy in hyperaldosteronism","volume":"21","author":"Izzo","year":"2019","journal-title":"Journal of Clinical Hypertension (Greenwich)"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0250","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0255","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41440-021-00754-7","article-title":"Catheter-based ultrasound renal denervation in patients with resistant hypertension: The randomized, controlled REQUIRE trial","volume":"45","author":"Kario","year":"2022","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0260","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1520-037X.2001.00529.x","article-title":"Aerobic exercise and resting blood pressure: A meta-analytic review of randomized, controlled trials","volume":"4","author":"Kelley","year":"2001","journal-title":"Preventive Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0265","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3904\/kjim.2019.361","article-title":"Apparent treatment-resistant hypertension among ambulatory hypertensive patients: A cross-sectional study from 13 general hospitals","volume":"36","author":"Kim","year":"2021","journal-title":"Korean Journal of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0270","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/eurheartj\/eht200","article-title":"Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension","volume":"34","author":"Kiuchi","year":"2013","journal-title":"European Heart Journal"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0275","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0002-8703(84)90628-8","article-title":"Prevalence of sleep apnea syndrome among patients with essential hypertension","volume":"108","author":"Lavie","year":"1984","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0280","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41440-024-01988-x","article-title":"Prognosis of apparent treatment-resistant hypertension and poor adherence: A nationwide cohort study","volume":"48","author":"Lee","year":"2025","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0285","article-title":"Antihypertensive medication adherence and medical costs, health care use, and labor productivity among people with hypertension","volume":"13","author":"Lee","year":"2024","journal-title":"Journal of the American Heart Association"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0290","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/HYPERTENSIONAHA.117.09086","article-title":"Sustained reduction of blood pressure with baroreceptor activation therapy: Results of the 6-year open follow-up","volume":"69","author":"de Leeuw","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0295","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/VHRM.S40231","article-title":"Effects of CPAP on \u201cvascular\u201d risk factors in patients with obstructive sleep apnea and arterial hypertension","volume":"9","author":"Litvin","year":"2013","journal-title":"Vascular Health and Risk Management"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0300","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1097\/00004872-200112000-00022","article-title":"High prevalence of unrecognized sleep apnoea in drug-resistant hypertension","volume":"19","author":"Logan","year":"2001","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0305","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jamacardio.2021.2735","article-title":"Effect of exercise training on ambulatory blood pressure among patients with resistant hypertension: A randomized clinical trial","volume":"6","author":"Lopes","year":"2021","journal-title":"JAMA Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0310","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/s41440-022-00945-w","article-title":"The blood pressure response to acute exercise predicts the ambulatory blood pressure response to exercise training in patients with resistant hypertension: Results from the EnRicH trial","volume":"45","author":"Lopes","year":"2022","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0315","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/s41440-023-01229-7","article-title":"Aerobic exercise improves central blood pressure and blood pressure variability among patients with resistant hypertension: Results of the EnRicH trial","volume":"46","author":"Lopes","year":"2023","journal-title":"Hypertension Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0320","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1097\/HJH.0b013e32833b9c63","article-title":"Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: A randomized, controlled trial","volume":"28","author":"Lozano","year":"2010","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0325","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/jch.13429","article-title":"Antihypertensive therapy prescribing patterns and correlates of blood pressure control among hypertensive patients with chronic kidney disease","volume":"21","author":"Magvanjav","year":"2019","journal-title":"Journal of Clinical Hypertension (Greenwich)"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0330","first-page":"471","article-title":"Alcohol-mediated renal denervation using the peregrine system infusion catheter for treatment of hypertension","volume":"13","author":"Mahfoud","year":"2020","journal-title":"Journal of the American College of Cardiology: Cardiovascular Interventions"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0335","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0340","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s40620-021-00966-7","article-title":"Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: First Italian real-world experience","volume":"34","author":"Marin","year":"2021","journal-title":"Journal of Nephrology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0345","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","article-title":"2024 heart disease and stroke statistics: A report of US and global data from the American Heart Association","volume":"149","author":"Martin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0350","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2013.281250","article-title":"Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: The HIPARCO randomized clinical trial","volume":"310","author":"Mart\u00ednez-Garc\u00eda","year":"2013","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0355","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1097\/HJH.0000000000000977","article-title":"Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial","volume":"34","author":"Mathiassen","year":"2016","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0360","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1053\/j.ajkd.2009.09.014","article-title":"Hypertension awareness, treatment, and control in adults with CKD: Results from the chronic renal insufficiency cohort (CRIC) study","volume":"55","author":"Muntner","year":"2010","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0365","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.114.04852","article-title":"Effects of continuous positive airway pressure treatment on clinic and ambulatory blood pressures in patients with obstructive sleep apnea and resistant hypertension: A randomized controlled trial","volume":"65","author":"Muxfeldt","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0370","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/ajh\/hpu023","article-title":"Prevalence and associated factors of obstructive sleep apnea in patients with resistant hypertension","volume":"27","author":"Muxfeldt","year":"2014","journal-title":"American Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0375","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/heartjnl-2018-313599","article-title":"Global prevalence of resistant hypertension: A meta-analysis of data from 3.2 million patients","volume":"105","author":"Noubiap","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0380","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1097\/HJH.0000000000001025","article-title":"Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: Results from the DENERVHTA study - a randomized controlled trial","volume":"34","author":"Oliveras","year":"2016","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0385","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/HJH.0000000000000556","article-title":"Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension","volume":"33","author":"Ott","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0390","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.jash.2014.09.019","article-title":"Amiloride lowers blood pressure and attenuates urine plasminogen activation in patients with treatment-resistant hypertension","volume":"8","author":"Oxlund","year":"2014","journal-title":"Journal of the American Society of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0395","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1378\/chest.112.5.1253","article-title":"Influence of sleep apnea on 24-hour blood pressure","volume":"112","author":"Pankow","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0400","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1378\/chest.13-0085","article-title":"Effects of OSA treatment on BP in patients with resistant hypertension: A randomized trial","volume":"144","author":"Pedrosa","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0405","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8157858","article-title":"Combined aerobic and resistance exercises evokes longer reductions on ambulatory blood pressure in resistant hypertension: A randomized crossover trial","volume":"2020","author":"Pires","year":"2020","journal-title":"Cardiovascular Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0410","first-page":"568","article-title":"Antihypertensive medication adherence and subsequent healthcare utilization and costs","volume":"16","author":"Pittman","year":"2010","journal-title":"The American Journal of Managed Care"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0415","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/07420528.2012.701135","article-title":"Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring","volume":"30","author":"R\u00edos","year":"2013","journal-title":"Chronobiology International"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0420","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0149-2918(97)80018-5","article-title":"Variations in compliance among hypertensive patients by drug class: Implications for health care costs","volume":"19","author":"Rizzo","year":"1997","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0425","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1007\/s11739-023-03376-8","article-title":"Hypertension, uncontrolled hypertension and resistant hypertension: Prevalence, comorbidities and prescribed medications in 228,406 adults resident in urban areas. A population-based observational study","volume":"18","author":"Romano","year":"2023","journal-title":"Internal and Emergency Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0430","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.114.04019","article-title":"Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: Six-month results from the Prague-15 study","volume":"65","author":"Rosa","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0435","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1161\/HYPERTENSIONAHA.122.19744","article-title":"Blood pressure and cardiorenal outcomes with finerenone in chronic kidney disease in type 2 diabetes","volume":"79","author":"Ruilope","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0440","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/ndt\/gfae041","article-title":"A European Renal Association (ERA) synopsis for nephrology practice of the 2023 European Society of Hypertension (ESH) guidelines for the management of arterial hypertension","volume":"39","author":"Sarafidis","year":"2024","journal-title":"Nephrology, Dialysis, Transplantation"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0445","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): A multicentre, blinded, randomised, parallel-group, phase 3 trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0450","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.ijcard.2016.06.263","article-title":"Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients","volume":"220","author":"Schulz","year":"2016","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0455","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0002-9610(67)90034-7","article-title":"Chronic carotid sinus nerve stimulation in the treatment of essential hypertension","volume":"114","author":"Schwartz","year":"1967","journal-title":"American Journal of Surgery"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0460","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1161\/HYPERTENSIONAHA.119.14137","article-title":"Antihypertensive medication adherence and confirmation of true refractory hypertension","volume":"75","author":"Siddiqui","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0465","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Medical Care"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0470","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/HJH.0b013e3283652c61","article-title":"Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis","volume":"31","author":"Strauch","year":"2013","journal-title":"Journal of Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0475","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2215\/CJN.00550113","article-title":"Prevalence of apparent treatment-resistant hypertension among individuals with CKD","volume":"8","author":"Tanner","year":"2013","journal-title":"Clinical Journal of the American Society of Nephrology"},{"issue":"1","key":"10.1016\/j.pharmthera.2025.108875_bb0480","doi-asserted-by":"crossref","first-page":"810","DOI":"10.34067\/KID.0002072020","article-title":"Apparent treatment-resistant hypertension assessed by office and ambulatory blood pressure in chronic kidney disease-a report from the chronic renal insufficiency cohort study","volume":"360","author":"Thomas","year":"2020","journal-title":"Kidney"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0485","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/HYPERTENSIONAHA.115.06487","article-title":"Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: Report from the chronic renal insufficiency cohort study","volume":"67","author":"Thomas","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0490","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cvr\/cvad165","article-title":"Efficacy of pharmacological and interventional treatment for resistant hypertension: A network meta-analysis","volume":"120","author":"Tian","year":"2024","journal-title":"Cardiovascular Research"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0495","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ejvs.2006.11.025","article-title":"An implantable carotid sinus baroreflex activating system: Surgical technique and short-term utcome from a multi-center feasibility trial for the treatment of resistant hypertension","volume":"33","author":"Tordoir","year":"2007","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0500","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00392-016-1056-z","article-title":"Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: Data from the Greek renal denervation registry","volume":"106","author":"Tsioufis","year":"2017","journal-title":"Clinical Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0505","doi-asserted-by":"crossref","first-page":"835","DOI":"10.5664\/jcsm.3946","article-title":"Association of severe obstructive sleep apnea and elevated blood pressure despite antihypertensive medication use","volume":"10","author":"Walia","year":"2014","journal-title":"Journal of Clinical Sleep Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0510","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00392-019-01536-5","article-title":"Long-term effects of baroreflex activation therapy: 2-year follow-up data of the BAT neo system","volume":"109","author":"Wallbach","year":"2020","journal-title":"Clinical Research in Cardiology"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0515","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1161\/HYPERTENSIONAHA.115.06717","article-title":"Effects of baroreflex activation therapy on ambulatory blood pressure in patients with resistant hypertension","volume":"67","author":"Wallbach","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0520","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.hlc.2016.02.016","article-title":"Efficacy and safety of spironolactone in patients with resistant hypertension: A meta-analysis of randomised controlled trials","volume":"25","author":"Wang","year":"2016","journal-title":"Heart, Lung & Circulation"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0544","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","article-title":"A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Weber","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0525","doi-asserted-by":"crossref","first-page":"493","DOI":"10.7326\/0003-4819-136-7-200204020-00006","article-title":"Effect of aerobic exercise on blood pressure: A meta-analysis of randomized, controlled trials","volume":"136","author":"Whelton","year":"2002","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0530","series-title":"Global report on hypertension: The race against a silent killer","first-page":"1","author":"World Health Organization (WHO)","year":"2023"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0535","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3949\/ccjm.90a.22046","article-title":"Resistant hypertension: A stepwise approach","volume":"90","author":"Yahr","year":"2023","journal-title":"Cleveland Clinic Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2025.108875_bb0540","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/MLR.0000000000000515","article-title":"Association of antihypertensive medication adherence with healthcare use and medicaid expenditures for acute cardiovascular events","volume":"54","author":"Yang","year":"2016","journal-title":"Medical Care"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725825000877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T20:47:09Z","timestamp":1762030029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725825000877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":111,"alternative-id":["S0163725825000877"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108875","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of drug-resistant hypertension as a heterogeneous disorder","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2025.108875","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108875"}}